Orchid Pharma Ltd vs Vivimed Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 10, 2026

Key Highlights

The Latest Trading Price of Orchid Pharma Ltd is ₹ 704.1 as of 08 May 15:30 . The P/E Ratio of Orchid Pharma Ltd changed from 33.9 on March 2023 to 39.5 on March 2025 . This represents a CAGR of 5.23% over 3 yearsThe P/E Ratio of Vivimed Labs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Orchid Pharma Ltd changed from ₹ 10061 crore on March 2021 to ₹ 3940 crore on March 2025 . This represents a CAGR of -17.10% over 5 yearsThe Market Cap of Vivimed Labs Ltd changed from ₹ 131.42 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Orchid Pharma Ltd for the Dec '25 is ₹ 212.88 crore as compare to the Sep '25 revenue of ₹ 204.3 crore. This represent the growth of 4.2% The revenue of Vivimed Labs Ltd for the Dec '25 is ₹ 15.99 crore as compare to the Sep '25 revenue of ₹ 20.82 crore. This represent the decline of -23.2% The ebitda of Orchid Pharma Ltd for the Dec '25 is ₹ 0.06 crore as compare to the Sep '25 ebitda of ₹ 9.3 crore. This represent the decline of -99.35% The ebitda of Vivimed Labs Ltd for the Dec '25 is ₹ -10.92 crore as compare to the Sep '25 ebitda of ₹ -0.74 crore. This represent the growth of 1375% The net profit of Orchid Pharma Ltd changed from ₹ 28.27 crore to ₹ -12.15 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Vivimed Labs Ltd changed from ₹ -15.25 crore to ₹ -16.55 crore over 7 quarters. This represents a CAGR of 4.79% The Dividend Payout of Orchid Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vivimed Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Orchid Pharma Ltd

Orchid Pharma Limited, is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains.
Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products.
Antibiotics are life-saving drugs used to ght infections.
Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc.

About Vivimed Labs Ltd

Vivimed Labs Limited was originally incorporated on September 22, 1988 as a private limited company in the name of Emgi Pharmaceuticals & Chemicals Pvt Ltd. On April 21, 1994, the company got converted into a public limited company and the name was changed to Emgi Pharmaceuticals & Chemicals Ltd and thereafter, the Company name was finally changed to Vivimed Labs Limited on April 22, 1997. The Company is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry), Pharmaceuticals, API's and Formulations.
The company has strong presence in the areas of Health & Personal Care, Contract Research and Manufacturing.
The company has four subsidiary companies, namely Creative Health Care Pvt Ltd, Vivimed Holdings Ltd (Hong Kong), Vivimed Labs Europe Ltd (UK) and Vivimed Labs USA Inc.

FAQs for the comparison of Orchid Pharma Ltd and Vivimed Labs Ltd

Which company has a larger market capitalization, Orchid Pharma Ltd or Vivimed Labs Ltd?

Market cap of Orchid Pharma Ltd is 3,571 Cr while Market cap of Vivimed Labs Ltd is 57 Cr

What are the key factors driving the stock performance of Orchid Pharma Ltd and Vivimed Labs Ltd?

The stock performance of Orchid Pharma Ltd and Vivimed Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Orchid Pharma Ltd and Vivimed Labs Ltd?

As of May 10, 2026, the Orchid Pharma Ltd stock price is INR ₹704.1. On the other hand, Vivimed Labs Ltd stock price is INR ₹6.88.

How do dividend payouts of Orchid Pharma Ltd and Vivimed Labs Ltd compare?

To compare the dividend payouts of Orchid Pharma Ltd and Vivimed Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.